Intended audience:
This document is intended as a reference and source of information to the following audiences:
Nursing staff who handle cytotoxic chemotherapy (Oncology / Haematology plus other areas)
Pharmacy Aseptic Services Staff and Chief Pharmacists
Hospital senior management and Health and Safety / Risk Assessment / governance leads
Outsourced or in-house cleaning / portering service providers
NHS policy makers
In order to implement the contents of this document, it is recommended that a group consisting of the stakeholders named above performs a gap analysis to identify changes required. Change implementation should then follow the individual organisation’s policies for medicines management as appropriate.

Overview / Scope
This document provides guidance on the handling of cytotoxic chemotherapy and its focus is on traditional small molecule chemotherapy although there are references to biological therapies including monoclonal antibodies which are being used in increasing numbers.



Print this page